Prologis, Teledyne Technologies, Hamilton Lane, Ascendis Pharma A/S, Acadia Realty Trust, Canopy Growth, and Hercules Capital are the seven Growth stocks to watch today, according to MarketBeat’s stock screener tool. Growth stocks are shares of companies whose revenues and earnings are projected to grow at an above-average rate compared with the broader market. These companies typically reinvest profits into expansion, research and development, or acquisitions rather than paying dividends, and they often trade at higher price-to-earnings ratios based on optimistic growth expectations. Investors in growth stocks aim for substantial capital appreciation over time, accepting that these stocks can be more volatile. These companies had the highest dollar trading volume of any Growth stocks within the last several days.
Prologis (PLD)
Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.
Teledyne Technologies (TDY)
Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.
Read Our Latest Research Report on TDY
Hamilton Lane (HLNE)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Read Our Latest Research Report on HLNE
Ascendis Pharma A/S (ASND)
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.
Read Our Latest Research Report on ASND
Acadia Realty Trust (AKR)
Read Our Latest Research Report on AKR
Canopy Growth (CGC)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Read Our Latest Research Report on CGC
Hercules Capital (HTGC)
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies.
Read Our Latest Research Report on HTGC
Featured Articles
- MarketBeat’s Top Five Stocks to Own in October 2025
- Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback
- 3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
- A Copper Catalyst: Why Freeport-McMoRan Is Positioned to Rebound
- MarketBeat Week in Review – 09/29 – 10/03
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?